Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 30:S3 2007
DOI: 10.2337/dc07-S003
© 2007 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Introduction
Summary of Revision

Summary of Revisions for the 2007 Clinical Practice Recommendations

Beginning with the 2005 supplement, the Clinical Practice Recommendations contained only the "Standards of Medical Care in Diabetes" and selected other position statements. This change was made to emphasize the importance of the "Standards" as the best source to determine ADA recommendations. The position statements in the supplement are updated yearly. Position statements not included in the supplement will be updated as necessary and republished when completed. A list of the position statements not included in this supplement appears on p. S93.

Additions to the Standards of Medical Care in Diabetes

Revised Position Statements

  • Nutrition Recommendations and Interventions for Diabetes

Additions to the Standards of Medical Care in Diabetes

  • Diabetes care
    • Algorithm for the initiation and adjustment of therapy for type 2 diabetes

  • Emergency and disaster preparedness
  • Table of agents to treat DPN pain
  • Celiac disease
  • Revised initial evaluation table (Table 5)

Summary of Revisions to the Standards of Medical Care in Diabetes

  • Diabetes care
    • Components of the comprehensive diabetes evaluation revised
    • Lowering A1C has been associated with a reduction of microvascular and neuropathic complications of diabetes (A) and possibly macrovascular disease (B)

  • Medical nutrition therapy (MNT) extensively revised
  • Nephropathy
    • Reduction of protein intake to 0.8–1.0 g/kg body wt per day in individuals with diabetes and the earlier stages of chronic kidney disease (CKD) and to 0.8 g/kg body wt per day in the later stages of CKD may improve measures of renal function (e.g., urine albumin excretion rate and glomerular filtration rate) and is recommended (B)

  • Celiac disease
    • Children with positive antibodies should be referred to a gastroenterologist for evaluation (E)
    • Children with confirmed celiac disease should have consultation with a dietitian and placed on a gluten-free diet (E)

  • Diabetes care in the hospital
    • Using correction dose or "supplemental" insulin to correct premeal hyperglycemia in addition to scheduled prandial and basal insulin is recommended (C)

  • Preconception care
    • Based on recent research, ACE inhibitors should also be discontinued before conception (E)

  • Diabetes care in the school and day care setting
    • A 504 plan should be developed and implemented by the family, school nurse, and diabetes health care team (E)

Members of the Professional Practice Committee

Vivian Fonseca, MD, Chair

Lawrence Blonde, MD

Hertzel C. Gerstein, MD, Msc, FRCPC

Irl Hirsch, MD

Steven Kahn, MB, ChB

Mary T. Korytkowski, MN, MD, MSN

Elizabeth Mayer-Davis, MS, PhD, RD

James Meigs, MD, MPH

Janet H. Silverstein, MD

Geralyn R. Spollett, MSN, C-ANP, CDE

Judith Wylie-Rossett, RD, EdD


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. I. Yilmaz, M. Saglam, A. R. Qureshi, J. J. Carrero, K. Caglar, T. Eyileten, A. Sonmez, E. Cakir, Y. Oguz, A. Vural, et al.
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1621 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Weykamp, W G. John, A. Mosca, T. Hoshino, R. Little, J.-O. Jeppsson, I. Goodall, K. Miedema, G. Myers, H. Reinauer, et al.
The IFCC Reference Measurement System for HbA1c: A 6-Year Progress Report
Clin. Chem., February 1, 2008; 54(2): 240 - 248.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum